Fitur visualisasi ini dikembangkan menggunakan pendekatan Graph Theory untuk memetakan hubungan polifarmasi dan molekuler. Entitas (Obat, Target, Gen) direpresentasikan sebagai Simpul (Nodes), sedangkan hubungan biologisnya sebagai Sisi (Edges).
drugbank-id dan name pada skema XML DrugBank.targets/target yang memuat polipeptida sasaran.gene-name dan varian snp-effects.Tata letak grafik menggunakan algoritma Force-Directed Graph (Barnes-Hut). Model fisika ini menerapkan gaya tolak-menolak antar simpul (Gravitasi: -3000) agar tidak tumpang tindih, serta gaya pegas (Spring: 0.04) pada garis penghubung untuk fleksibilitas interaksi.
| Ceftriaxone | The risk or severity of adverse effects can be increased when Calcium cation is combined with Ceftriaxone. |
| Dobutamine | The therapeutic efficacy of Dobutamine can be decreased when used in combination with Calcium cation. |
| Calcium acetate | The risk or severity of adverse effects can be increased when Calcium cation is combined with Calcium acetate. |
| Digoxin | Calcium cation may increase the arrhythmogenic and cardiotoxic activities of Digoxin. |
| Acetyldigitoxin | Calcium cation may increase the arrhythmogenic and cardiotoxic activities of Acetyldigitoxin. |
| Deslanoside | Calcium cation may increase the arrhythmogenic and cardiotoxic activities of Deslanoside. |
| Ouabain | Calcium cation may increase the arrhythmogenic and cardiotoxic activities of Ouabain. |
| Digitoxin | Calcium cation may increase the arrhythmogenic and cardiotoxic activities of Digitoxin. |
| Oleandrin | Calcium cation may increase the arrhythmogenic and cardiotoxic activities of Oleandrin. |
| Cymarin | Calcium cation may increase the arrhythmogenic and cardiotoxic activities of Cymarin. |
| Proscillaridin | Calcium cation may increase the arrhythmogenic and cardiotoxic activities of Proscillaridin. |
| Metildigoxin | Calcium cation may increase the arrhythmogenic and cardiotoxic activities of Metildigoxin. |
| Lanatoside C | Calcium cation may increase the arrhythmogenic and cardiotoxic activities of Lanatoside C. |
| Gitoformate | Calcium cation may increase the arrhythmogenic and cardiotoxic activities of Gitoformate. |
| Acetyldigoxin | Calcium cation may increase the arrhythmogenic and cardiotoxic activities of Acetyldigoxin. |
| Peruvoside | Calcium cation may increase the arrhythmogenic and cardiotoxic activities of Peruvoside. |
| Doxycycline | The serum concentration of Doxycycline can be decreased when it is combined with Calcium cation. |
| Lymecycline | The serum concentration of Lymecycline can be decreased when it is combined with Calcium cation. |
| Clomocycline | The serum concentration of Clomocycline can be decreased when it is combined with Calcium cation. |
| Oxytetracycline | The serum concentration of Oxytetracycline can be decreased when it is combined with Calcium cation. |
| Demeclocycline | The serum concentration of Demeclocycline can be decreased when it is combined with Calcium cation. |
| Tetracycline | The serum concentration of Tetracycline can be decreased when it is combined with Calcium cation. |
| Metacycline | The serum concentration of Metacycline can be decreased when it is combined with Calcium cation. |
| Minocycline | The serum concentration of Minocycline can be decreased when it is combined with Calcium cation. |
| Sarecycline | The serum concentration of Sarecycline can be decreased when it is combined with Calcium cation. |
| Omadacycline | The serum concentration of Omadacycline can be decreased when it is combined with Calcium cation. |
| Penimepicycline | The serum concentration of Penimepicycline can be decreased when it is combined with Calcium cation. |
| Methyclothiazide | Methyclothiazide may decrease the excretion rate of Calcium cation which could result in a higher serum level. |
| Chlorthalidone | Chlorthalidone may decrease the excretion rate of Calcium cation which could result in a higher serum level. |
| Bendroflumethiazide | Bendroflumethiazide may decrease the excretion rate of Calcium cation which could result in a higher serum level. |
| Metolazone | Metolazone may decrease the excretion rate of Calcium cation which could result in a higher serum level. |
| Benzthiazide | Benzthiazide may decrease the excretion rate of Calcium cation which could result in a higher serum level. |
| Hydroflumethiazide | Hydroflumethiazide may decrease the excretion rate of Calcium cation which could result in a higher serum level. |
| Indapamide | Indapamide may decrease the excretion rate of Calcium cation which could result in a higher serum level. |
| Chlorothiazide | Chlorothiazide may decrease the excretion rate of Calcium cation which could result in a higher serum level. |
| Hydrochlorothiazide | Hydrochlorothiazide may decrease the excretion rate of Calcium cation which could result in a higher serum level. |
| Trichlormethiazide | Trichlormethiazide may decrease the excretion rate of Calcium cation which could result in a higher serum level. |
| Polythiazide | Polythiazide may decrease the excretion rate of Calcium cation which could result in a higher serum level. |
| Quinethazone | Quinethazone may decrease the excretion rate of Calcium cation which could result in a higher serum level. |
| Cyclopenthiazide | Cyclopenthiazide may decrease the excretion rate of Calcium cation which could result in a higher serum level. |
| Epitizide | Epitizide may decrease the excretion rate of Calcium cation which could result in a higher serum level. |
| Calcitriol | The risk or severity of adverse effects can be increased when Calcitriol is combined with Calcium cation. |
| Calcifediol | The risk or severity of adverse effects can be increased when Calcifediol is combined with Calcium cation. |
| Ergocalciferol | The risk or severity of adverse effects can be increased when Ergocalciferol is combined with Calcium cation. |
| Cholecalciferol | The risk or severity of adverse effects can be increased when Cholecalciferol is combined with Calcium cation. |
| Paricalcitol | The risk or severity of adverse effects can be increased when Paricalcitol is combined with Calcium cation. |
| Dihydrotachysterol | The risk or severity of adverse effects can be increased when Dihydrotachysterol is combined with Calcium cation. |
| Alfacalcidol | The risk or severity of adverse effects can be increased when Alfacalcidol is combined with Calcium cation. |
| Calcipotriol | The risk or severity of adverse effects can be increased when Calcipotriol is combined with Calcium cation. |
| Seocalcitol | The risk or severity of adverse effects can be increased when Seocalcitol is combined with Calcium cation. |
| Inecalcitol | The risk or severity of adverse effects can be increased when Inecalcitol is combined with Calcium cation. |
| Becocalcidiol | The risk or severity of adverse effects can be increased when Becocalcidiol is combined with Calcium cation. |
| Eldecalcitol | The risk or severity of adverse effects can be increased when Eldecalcitol is combined with Calcium cation. |
| 1alpha,24S-Dihydroxyvitamin D2 | The risk or severity of adverse effects can be increased when 1alpha,24S-Dihydroxyvitamin D2 is combined with Calcium cation. |
| Elocalcitol | The risk or severity of adverse effects can be increased when Elocalcitol is combined with Calcium cation. |
| Maxacalcitol | The risk or severity of adverse effects can be increased when Maxacalcitol is combined with Calcium cation. |
| Doxercalciferol | The risk or severity of adverse effects can be increased when Doxercalciferol is combined with Calcium cation. |
| Vitamin D | The risk or severity of adverse effects can be increased when Vitamin D is combined with Calcium cation. |
| 1alpha-Hydroxyvitamin D5 | The risk or severity of adverse effects can be increased when 1alpha-Hydroxyvitamin D5 is combined with Calcium cation. |
| Tacalcitol | The risk or severity of adverse effects can be increased when Tacalcitol is combined with Calcium cation. |
| Previtamin D(3) | The risk or severity of adverse effects can be increased when Previtamin D(3) is combined with Calcium cation. |
| Aminocaproic acid | The risk or severity of adverse effects can be increased when Aminocaproic acid is combined with Calcium cation. |
| Isradipine | The therapeutic efficacy of Isradipine can be decreased when used in combination with Calcium cation. |
| Diltiazem | The therapeutic efficacy of Diltiazem can be decreased when used in combination with Calcium cation. |
| Trimethadione | The therapeutic efficacy of Trimethadione can be decreased when used in combination with Calcium cation. |
| Amlodipine | The therapeutic efficacy of Amlodipine can be decreased when used in combination with Calcium cation. |
| Nimodipine | The therapeutic efficacy of Nimodipine can be decreased when used in combination with Calcium cation. |
| Nisoldipine | The therapeutic efficacy of Nisoldipine can be decreased when used in combination with Calcium cation. |
| Lercanidipine | The therapeutic efficacy of Lercanidipine can be decreased when used in combination with Calcium cation. |
| Cinnarizine | The therapeutic efficacy of Cinnarizine can be decreased when used in combination with Calcium cation. |
| Ethosuximide | The therapeutic efficacy of Ethosuximide can be decreased when used in combination with Calcium cation. |
| Nicardipine | The therapeutic efficacy of Nicardipine can be decreased when used in combination with Calcium cation. |
| Magnesium sulfate | The therapeutic efficacy of Magnesium sulfate can be decreased when used in combination with Calcium cation. |
| Verapamil | The therapeutic efficacy of Verapamil can be decreased when used in combination with Calcium cation. |
| Zonisamide | The therapeutic efficacy of Zonisamide can be decreased when used in combination with Calcium cation. |
| Felodipine | The therapeutic efficacy of Felodipine can be decreased when used in combination with Calcium cation. |
| Nitrendipine | The therapeutic efficacy of Nitrendipine can be decreased when used in combination with Calcium cation. |
| Perhexiline | The therapeutic efficacy of Perhexiline can be decreased when used in combination with Calcium cation. |
| Nifedipine | The therapeutic efficacy of Nifedipine can be decreased when used in combination with Calcium cation. |
| Amiodarone | The therapeutic efficacy of Amiodarone can be decreased when used in combination with Calcium cation. |
| Carvedilol | The therapeutic efficacy of Carvedilol can be decreased when used in combination with Calcium cation. |
| Bepridil | The therapeutic efficacy of Bepridil can be decreased when used in combination with Calcium cation. |
| Mibefradil | The therapeutic efficacy of Mibefradil can be decreased when used in combination with Calcium cation. |
| Nimesulide | The therapeutic efficacy of Nimesulide can be decreased when used in combination with Calcium cation. |
| Prenylamine | The therapeutic efficacy of Prenylamine can be decreased when used in combination with Calcium cation. |
| Cyclandelate | The therapeutic efficacy of Cyclandelate can be decreased when used in combination with Calcium cation. |
| Flunarizine | The therapeutic efficacy of Flunarizine can be decreased when used in combination with Calcium cation. |
| Fluspirilene | The therapeutic efficacy of Fluspirilene can be decreased when used in combination with Calcium cation. |
| Clevidipine | The therapeutic efficacy of Clevidipine can be decreased when used in combination with Calcium cation. |
| Methsuximide | The therapeutic efficacy of Methsuximide can be decreased when used in combination with Calcium cation. |
| Seletracetam | The therapeutic efficacy of Seletracetam can be decreased when used in combination with Calcium cation. |
| Nylidrin | The therapeutic efficacy of Nylidrin can be decreased when used in combination with Calcium cation. |
| Ziconotide | The therapeutic efficacy of Ziconotide can be decreased when used in combination with Calcium cation. |
| Dotarizine | The therapeutic efficacy of Dotarizine can be decreased when used in combination with Calcium cation. |
| Xylometazoline | The therapeutic efficacy of Xylometazoline can be decreased when used in combination with Calcium cation. |
| Nilvadipine | The therapeutic efficacy of Nilvadipine can be decreased when used in combination with Calcium cation. |
| Tranilast | The therapeutic efficacy of Tranilast can be decreased when used in combination with Calcium cation. |
| Fasudil | The therapeutic efficacy of Fasudil can be decreased when used in combination with Calcium cation. |
| Agmatine | The therapeutic efficacy of Agmatine can be decreased when used in combination with Calcium cation. |
| Fendiline | The therapeutic efficacy of Fendiline can be decreased when used in combination with Calcium cation. |